Patel; Narendra Kumar B.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Patel; Narendra Kumar B..The latest application filed is for "pyrazolopyrimidine compounds".
Company Profile
9.23.25
- Patel; Narendra Kumar B. - Brampton CA
- Patel; Narendra Kumar B. - Scarborough CA
- - Brampton CA
Patent Activity
| Patent | Date |
|---|---|
| Pyrazolopyrimidine Compounds App 20220204511 - Laufer; Radoslaw ; et al. | 2022-06-30 |
| Hpk1 Inhibitors And Methods Of Using Same App 20220002313 - Sampson; Peter Brent ; et al. | 2022-01-06 |
| HPK1 inhibitors and methods of using same Grant 11,059,832 - Sampson , et al. July 13, 2 | 2021-07-13 |
| Pyrazolopyrimidine Compounds App 20210009595 - Laufer; Radoslaw ; et al. | 2021-01-14 |
| Hpk1 Inhibitors And Methods Of Using Same App 20200190104 - Sampson; Peter Brent ; et al. | 2020-06-18 |
| Pyrazolopyrimidine compounds Grant 10,570,143 - Liu , et al. Feb | 2020-02-25 |
| HPK1 inhibitors and methods of using same Grant 10,501,474 - Sampson , et al. Dec | 2019-12-10 |
| Kinase inhibitors and method of treating cancer with same Grant RE47,731 - Sampson , et al. Nov | 2019-11-19 |
| Pyrazolopyrimidine Compounds App 20190322669 - Laufer; Radoslaw ; et al. | 2019-10-24 |
| Kinase inhibitors and method of treating cancer Grant 10,358,436 - Sampson , et al. | 2019-07-23 |
| Pyrazolopyrimidine Compounds App 20190040074 - Liu; Yong ; et al. | 2019-02-07 |
| Pyrazolopyrimidine compounds Grant 10,167,289 - Laufer , et al. J | 2019-01-01 |
| Pyrazolopyrimidine compounds Grant 10,106,545 - Liu , et al. October 23, 2 | 2018-10-23 |
| Kinase Inhibitors And Method Of Treating Cancer App 20180282306 - Sampson; Peter Brent ; et al. | 2018-10-04 |
| Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones Grant 10,077,255 - Cumming , et al. September 18, 2 | 2018-09-18 |
| Hpk1 Inhibitors And Methods Of Using Same App 20180179221 - Sampson; Peter Brent ; et al. | 2018-06-28 |
| Synthesis Of Chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones App 20180105511 - Cumming; Graham ; et al. | 2018-04-19 |
| Kinase inhibitors and method of treating cancer Grant 9,907,800 - Sampson , et al. March 6, 2 | 2018-03-06 |
| Pyrazolopyrimidine Compounds App 20170320881 - Laufer; Radoslaw ; et al. | 2017-11-09 |
| Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones Grant 9,796,703 - Cumming , et al. October 24, 2 | 2017-10-24 |
| Synthesis Of Chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones App 20170226088 - Cumming; Graham ; et al. | 2017-08-10 |
| Pyrazolopyrimidine Compounds App 20170217966 - Liu; Yong ; et al. | 2017-08-03 |
| Pyrazolopyrimidine compounds Grant 9,657,025 - Laufer , et al. May 23, 2 | 2017-05-23 |
| Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones Grant 9,579,327 - Cumming , et al. February 28, 2 | 2017-02-28 |
| Indazole compounds as kinase inhibitors and method of treating cancer with same Grant 9,580,390 - Pauls , et al. February 28, 2 | 2017-02-28 |
| Pyrazolopyrimidine compounds Grant 9,573,954 - Liu , et al. February 21, 2 | 2017-02-21 |
| Pyrazolopyrimidine Compounds App 20160137651 - Laufer; Radoslaw ; et al. | 2016-05-19 |
| Kinase Inhibitors And Method Of Treating Cancer App 20160045511 - Sampson; Peter Brent ; et al. | 2016-02-18 |
| Pyrazolopyrimidine Compounds App 20150299203 - Liu; Yong ; et al. | 2015-10-22 |
| Kinase inhibitors and method of treating cancer Grant 9,139,563 - Sampson , et al. September 22, 2 | 2015-09-22 |
| Synthesis Of Chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones App 20150133677 - Cumming; Graham ; et al. | 2015-05-14 |
| Kinase inhibitors and method of treating cancer with same Grant 8,999,968 - Sampson , et al. April 7, 2 | 2015-04-07 |
| Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones Grant 8,921,545 - Cumming , et al. December 30, 2 | 2014-12-30 |
| Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones Grant 08921545 - | 2014-12-30 |
| Indazole Compounds As Kinase Inhibitors And Method Of Treating Cancer With Same App 20140371202 - Pauls; Heinz W. ; et al. | 2014-12-18 |
| Kinase Inhibitors And Method Of Treating Cancer With Same App 20140051679 - Pauls; Heinz W. ; et al. | 2014-02-20 |
| Kinase Inhibitors And Method Of Treating Cancer With Same App 20140045822 - Sampson; Peter Brent ; et al. | 2014-02-13 |
| Kinase Inhibitors And Method Of Treating Cancer App 20140045838 - Sampson; Peter Brent ; et al. | 2014-02-13 |
| Kinase inhibitors and method of treating cancer Grant 8,481,533 - Sampson , et al. July 9, 2 | 2013-07-09 |
| Kinase inhibitors and method of treating cancer with same Grant 8,481,525 - Sampson , et al. July 9, 2 | 2013-07-09 |
| Kinase Inhibitors And Method Of Treating Cancer With Same App 20130096301 - Cumming; Graham ; et al. | 2013-04-18 |
| Kinase Inhibitors And Method Of Treating Cancer App 20120264800 - SAMPSON; Peter Brent ; et al. | 2012-10-18 |
| Kinase inhibitors and method of treating cancer Grant 8,263,596 - Sampson , et al. September 11, 2 | 2012-09-11 |
| Kinase Inhibitors And Method Of Treating Cancer With Same App 20120149686 - Sampson; Peter B. ; et al. | 2012-06-14 |
| Kinase Inhibitors And Method Of Treating Cancer App 20110263598 - Sampson; Peter B. ; et al. | 2011-10-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 